Pediatric Readmissions: Development of a New Federally-Sponsored - - PowerPoint PPT Presentation

pediatric readmissions development of a new federally
SMART_READER_LITE
LIVE PREVIEW

Pediatric Readmissions: Development of a New Federally-Sponsored - - PowerPoint PPT Presentation

Pediatric Readmissions: Development of a New Federally-Sponsored Measure Mari M. Nakamura, MD, MPH Boston Childrens Hospital Center of Excellence for Pediatric Quality Measurement 1 Why Measure and Prevent Readmissions?


slide-1
SLIDE 1

Pediatric Readmissions: Development of a New Federally-Sponsored Measure

Mari M. Nakamura, MD, MPH

Boston Children’s Hospital Center of Excellence for Pediatric Quality Measurement

1 ¡

slide-2
SLIDE 2

Why Measure and Prevent Readmissions?

Readmissions are

  • A potential signal of increased disease morbidity
  • A patient-centered quality outcome
  • Reflect effectiveness of care coordination and care

transitions

  • Responsible for exposure to safety risks of

hospitalization

  • Disruptive to patients and families
  • Costly
slide-3
SLIDE 3

Adult Readmissions Overview

  • CMS publicly reports 30-day Medicare readmission

rates for:

− Acute myocardial infarction (20%) − Heart failure (25%) − Pneumonia (18%)

  • Reporting for all-condition readmissions and

readmissions for other specific conditions is coming

  • Rates for adults show significant variation across

hospitals

− Suggests some readmissions might be preventable

  • CMS reduces Medicare payments to hospitals with

readmission rates significantly above average

slide-4
SLIDE 4

Pediatric Readmission Measure Development Process

  • Literature review
  • Expert interviews
  • Exploratory analytical work, including analysis of pediatric

readmission prevalence

  • Development of all-condition measure
  • Development of condition-specific measures
  • Pilot testing of measures

4 ¡

slide-5
SLIDE 5

Measure Outcome

# of index admissions with ≥1 readmission within 30 days Total # of index admissions

5 ¡

slide-6
SLIDE 6

Measure Focus

  • Population: Patients aged <18 years old
  • Facilities: General acute care hospitals, including

children’s hospitals

  • Data source: Administrative claims (using ICD-9-

CM codes)

6 ¡

slide-7
SLIDE 7

Exclusions

Hospitalizations for:

  • Birth of healthy newborns
  • Mental health conditions
  • Obstetric care, including labor and delivery

Readmissions for:

  • Chemotherapy
  • Planned procedures

7 ¡

slide-8
SLIDE 8

Adjustment

Readmission rates adjusted to account for differences in hospitals’ patient populations

  • Age
  • Gender
  • Chronic conditions
  • Insurance status

8 ¡

slide-9
SLIDE 9

Variation in Pediatric Readmissions

All Admissions Anemia/Neutropenia Ventricular Shunt Sickle Cell Crisis Seizure Gastroenteritis Upper Resp. Infect. Pneumonia Appendectomy Bronchiolitis Asthma

Adjusted 30-Day Readmission Rate Variation Across 72 Children’s Hospitals for Condition-Specific Admissions

Significant variation in readmission rates across hospitals (p<0.001) * * * * * * * * * *

9 ¡

Berry et al., JAMA , 2013

slide-10
SLIDE 10

Case-Mix-Adjusted Readmission Rates: New York, 2008

10 ¡

10 20 30

Adjus ted R ate (%)

S ignificantly above overall rate S ignificantly below overall rate

5.7- AHRQ Revisit dataset

slide-11
SLIDE 11

Next Steps

  • Pilot testing by the New York State Quality and

Safety Office

– Other states?

  • Development of condition-specific readmission

measures

– Appendectomy – Lower respiratory infection – Potentially others, such as mental health conditions?

  • Exploration of reasons for readmission

11 ¡

slide-12
SLIDE 12

Potential Users of Measure

  • CMS
  • States

– By Medicaid/SCHIP programs – For state-wide reporting (using all-payer claims datasets)

  • Private insurers
  • Hospitals

12 ¡

slide-13
SLIDE 13

Acknowledgments

The following people have participated in development of this measure: Funding: AHRQ/CMS U18HS020513 Jay G. Berry, MD, MPH Maria C. Bryant, BA Jeremy Y. Feng, AB Jisun Jang, MA Ashish K. Jha, MD, MPH William J. Kaplan, BA David J. Klein, MS Samuel S. Loren, AB Mari M. Nakamura, MD, MPH Carter R. Petty, AM Sangeeta Rana, MBBS, MPH Mark A. Schuster, MD, PhD Sara L. Toomey, MD, MPhil, MSc, MPH Sandra A. Williams, SM Alan M. Zaslavsky, PhD

13 ¡